Mr Thyer offers specialist management of prostate cancer.
Mr Thyer has a special interest in robotic and laparoscopic surgery for prostate and kidney cancer but also performs surgery for many other urological conditions.
Some prostate cancer is aggressive and requires treatment to prevent it spreading or causing death. Most prostate cancer however, is low-risk, tends to grow slowly and rarely spreads.
Men with slow growing, low-risk prostate cancers tend to die of non-prostate cancer causes. As urologists we therefore recommend Active Surveillance (AS) rather than treatment to men in this group. Active surveillance consists of regular blood tests, examinations, MRI and biopsies aimed at identifying cancer progression. Cancers that lie dormant over time can continue with surveillance, those that show signs of progression require treatment.
The PRIAS study is the largest continuous study of men undergoing AS for prostate cancer. The following questions about AS were answered in the study:
Of the men that discontinue AS about 2/3 are due to cancer progression and 1/3 due to patient desire for treatment
Pathology showed 2/3 had intermediate or high risk prostate cancer and 1/3 had low-risk prostate cancer
Of the 5000 men enrolled in the study about 50 developed incurable disease by the end of the 10 year period. This is a rate of about 1%. Of these:
Mr Thyer will follow the following protocol for all men on AS: